Burning Mouth Syndrome: Symptoms and Management
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Improved symptoms
研究概览
简要总结
This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.
详细描述
Why are we doing this research study?
This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.
What are some of the important aspects of this research study that I should be aware of?
Timeframe: 2 weeks intervention
Use the oral cooling spray; "Dr.B's Elixir" as directed
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Have buring mouth syndrome or experience oral burn
- •Live in the United States
- •At least 18 years old
- •Having been diagnosed or suspected diagnosis of burning mouth syndrome or suffer from chronic oral burn without any identifiable causative lesion
- •No tongue or cheek piercings
- •No history of cancer
- •No recent or scheduled dental treatment
- •No history of gum disease
- •No aversions to mint or hop extracts
排除标准
- •Have recently undergone dental treatment in the last three months or have plans to undergo dental treatment (e.g., fillings, crowns, root canals, extractions, or other dental procedures) in the coming month.
- •Have started any new treatments for BMS in the last 3 months or have plans to start new treatments in the coming month.
结局指标
主要结局
Improved symptoms
时间窗: 2 weeks
Frequency, severity, and duration of oral burn between regular treatment decreases after 2 weeks of using the oral spray
次要结局
未报告次要终点
研究者
Alissa Nolden
Assistant Professor
University of Massachusetts, Amherst